Kimia Biosciences Ltd receives approval of advance authorisation

Kimia Biosciences Limited has received the approval of Advance Authorisation License of Gliclazide BP an API from the office of the Additional Director General of Foreign Trade, CLA Delhi, under Directorate General of Foreign Trade.

Shares of Kimia Biosciences Ltd was last trading in BSE at Rs. 35.34 as compared to the previous close of Rs. 37.24. The total number of shares traded during the day was 5650 in over 33 trades.

The stock hit an intraday high of Rs. 38.67 and intraday low of 35.10. The net turnover during the day was Rs. 201646.00.

Source : Equity Bulls

Keywords

KimiaBiosciences INE285U01025 Pharmaceuticals Approval AdvanceAuthorisationLicense GliclazideBP API DGFT